Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Xalkori

Crizotinib

Open in the dashboard

Part D claims

1,463

Prescriptions dispensed, refills included

Drug cost

$28,283,482

Paid at the pharmacy, in all

Prescribers

115

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,463 claims for Xalkori (crizotinib) from 115 prescribers, at a total drug cost of $28.3 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 36 states and territories
Part D claims for Xalkori by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 15 197 $3,858,709
NY 10 151 $3,123,275
MA 9 128 $2,173,857
PA 11 127 $2,564,968
MN 6 72 $1,247,012
NC 5 63 $971,409
TX 5 60 $1,192,050
MD 4 50 $855,936
OH 4 49 $900,847
NJ 4 49 $991,591
FL 3 38 $818,468
TN 3 37 $694,498
MO 3 36 $814,653
IL 3 36 $599,112
AZ 3 35 $814,881
The other 21 states and territories
State Prescribers Claims Drug cost
IA 2 31 $709,147
OK 2 27 $348,496
SC 2 26 $580,587
KS 2 25 $553,925
NM 2 24 $405,746
WA 2 24 $407,736
NH 1 12 $274,509
HI 1 12 $274,509
MS 1 12 $247,066
AR 1 12 $252,282
SD 1 12 $274,508
WI 1 12 $119,332
PR 1 12 $272,099
ID 1 12 $251,609
IN 1 12 $133,813
VA 1 12 $274,508
MI 1 12 $270,484
MT 1 12 $257,557
ME 1 12 $293,024
CO 1 11 $231,900
OR 1 11 $229,379

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 7 of 7
Part D claims for Xalkori by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 48 613 $11,890,389
Medical Oncology 28 368 $7,380,005
Nurse Practitioner 15 201 $3,454,137
Physician Assistant 8 95 $1,965,106
Internal Medicine 8 92 $1,898,653
Hematology 6 71 $1,193,794
Hematopoietic Cell Transplantation and Cellular Therapy 2 23 $501,397

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Jiahuai Tan Hematology-Oncology NY 25 $580,278 None on record
Alexander Drilon Medical Oncology NY 24 $580,108 None on record
Marilyn Norton Hematology-Oncology CA 24 $404,267 None on record
Daniel Buroker Medical Oncology IA 20 $457,514 None on record
Jeanne Vaughn Nurse Practitioner MA 20 $430,012 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record